The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor a (TNF) blockers, raising concerns of an associated risk and prompting an investigation…

Read The Full Article…The Risk Of Malignancy In Children May Be Increased By TNF Blockers Read more »

Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world’s first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs…

Read The Full Article…Boston Scientific Announces FDA Approval Of [...] Read more »

Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research justg published. It is the first time that this effect has been shown in humans. The study also finds that alcohol consumption reduces the risk of developing the disease, confirming the results of previous studies…

Read The Full Article…Rheumatoid Arthritis Severity Reduced By [...] Read more »

Treating back problems, one of the most bothersome medical problems, cost Americans more than $30 billion in 2007- up from $16 billion in 1997 (in 2007 dollars), according to the latest News and Numbers from the Agency for Healthcare Research and Quality…

Read The Full Article…AHRQ News And Numbers: Price Tag For Treating Back Problems Now [...] Read more »

Patients with osteoarthritis (OA) of the knee or hip who adhere to the recommended home physical therapy exercises and physically active lifestyle experience more improvement in pain, physical function, and self-perceived effect according to a study from researchers in The Netherlands…

Read The Full Article…Adherence To Recommended Exercise Improves Physical Function, Reduces Pain For OA Patients Read more »

Horizon Pharma, Inc…

Read The Full Article…Horizon Pharma, Inc. Announces Results Of Phase 3 Study Of LODOTRA® Demonstrate 12-Month Sustained Efficacy And Safety In Rheumatoid Arthritis Read more »

Unigene Laboratories, Inc. (OTCBB: UGNE) announced that Novartis and its license partner Nordic Bioscience [the "Sponsor"] have decided to continue the companies’ two-year, Phase III Study 2302 assessing safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee. Novartis has a worldwide license to produce recombinant calcitonin under Unigene’s patented SecraPep® E…

Read [...] Read more »

Slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as $10,000 per patient, new Johns Hopkins-led research suggests…

Read The Full Article…Diagnostic "Guidelines" A Barrier To Prompt Relief For Some Back Pain Read more »

Slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as $10,000 per patient, new Johns Hopkins-led research suggests…

Read The Full Article…Diagnostic "Guidelines" A Barrier To Prompt Relief For Some Back Pain Read more »

A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease (SCD)…

Read The Full Article…Novel Treatment For Pain In Sickle Cell Disease Read more »